You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Advances in the Management of COVID-19 Pneumonia: Learning From the Past to Navigate the Future

  • Authors: Lorenzo Dagna, MD, FACP, FEFIM(Hon); Evangelos J. Giamarellos-Bourboulis, MD, PhD; Mihai G. Netea, MD, PhD; W. Joost Wiersinga, MD, PhD
  • CPD Released: 3/4/2022
  • Valid for credit through: 3/4/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.75 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US critical care specialists, emergency medicine physicians, and infectious disease physicians.

The goal of this activity is to educate physicians on the management of patients with COVID-19 pneumonia.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Therapeutic rationale for IL-1 inhibition
    • Phases in the pathogenesis of COVID-19
    • Latest developments with cytokine targeted therapies in patients with COVID-19 pneumonia
  • Demonstrate greater confidence in their ability to
    • Identify patients with COVID-19 at risk of severe respiratory failure in clinical practice


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Disclosures for additional planners can be found here.


Faculty

  • Lorenzo Dagna, MD, FACP, FEFIM(Hon)

    Associate Professor of Medicine
    Head of Immunology, Rheumatology, Allergy and Rare Diseases Unit
    IRCCS San Raffaele Scientific Institute
    Milano, Italy

    Disclosures

    Consultant or advisor for: AbbVie; Amgen; AstraZeneca; Biogen; Boehringer-Ingelheim; Bristol-Myers Squibb; Celltrion; Eli Lilly and Company; Galapagos; GlaxoSmithKline; Janssen; Kiniksa Pharmaceuticals; Novartis; Pfizer; Roche; Sanofi-Genzyme; Swedish Orphan Biovitrium
    Research funding from: Bristol-Myers Squibb; Celgene; Kiniksa Pharmaceuticals; Mundipharma Pharmaceuticals; Novartis; Pfizer; Swedish Orphan Biovitrium

  • Evangelos J. Giamarellos-Bourboulis, MD, PhD

    Chairman
    European Sepsis Alliance
    Professor of Internal Medicine and Infectious Diseases
    National and Kapodistrian University of Athens
    Athens, Greece

    Disclosures

    Consultant or advisor for: Fab’nTech; InflaRx GmbH; UCB; Xbiotech Inc
    Speaker or member of speakers bureau for: Abbott; GlaxoSmithKline; Swedish Orphan Biovitrium; ThermoFisher Brahms GmbH
    Research funding from: Abbott; AbbVie; BioMerieux France; InflaRx GmbH; MSD; Novartis; Swedish Orphan Biovitrium; ThermoFisher Brahms GmbH; UCB; Xbiotech Inc.

  • Mihai G. Netea, MD, PhD

    Professor of Experimental Medicine
    Radboud University Medical Center
    Nijmegen, The Netherlands

    Disclosures

    Consultant or advisor for: Trained Therapeutix Discovery
    Research funding from: GlaxoSmithKline; Ono Pharma; Viiv Healthcare; Trained Therapeutix Discovery
    Ownership interest: Trained Therapeutix Discovery

  • W. Joost Wiersinga, MD, PhD

    Professor of Medicine
    Division of Infectious Diseases
    Amsterdam UMC
    Amsterdam, The Netherlands

    Disclosures

    Consultant or advisor for: GlaxoSmithKline; MSD; Swedish Orphan Biovitrium

Editors

  • Alessia Piazza, PhD

    Medical Education Director, WebMD Global, LLC 

    Disclosures

    Disclosure: Alessia Piazza, PhD, has disclosed no relevant financial relationships.

  • Eloise Ballard, PhD

    Scientific Content Manager, WebMD Global, LLC 

    Disclosures

    Disclosure: Eloise Ballard, PhD, has disclosed no relevant financial relationships.  

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC  

    Disclosures

    Amanda Jett, PharmD, BCACP has disclosed no relevant financial relationships.  

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.75 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Advances in the Management of COVID-19 Pneumonia: Learning From the Past to Navigate the Future

Authors: Lorenzo Dagna, MD, FACP, FEFIM(Hon); Evangelos J. Giamarellos-Bourboulis, MD, PhD; Mihai G. Netea, MD, PhD; W. Joost Wiersinga, MD, PhDFaculty and Disclosures

CPD Released: 3/4/2022

Valid for credit through: 3/4/2023

processing....

Note: The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. We continue to add to the collection of activities on this subject as new information becomes available. It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities. However, manufacturer names related to the approved COVID-19 vaccines are provided in this activity in an effort to promote clarity. The use of manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer.

Contents of This CPD Activity

All sections of this activity are required for credit.

Learnings From the Past: How Lessons From Sepsis Have Informed the Therapeutic Developments for COVID-19 Pneumonia​

Join our expert faculty as they discuss learnings from the development of sepsis therapeutics.
W. Joost Wiersinga, MD, PhD​​

Updates in the Management of COVID-19 Pneumonia: Following the Course of Disease

Join our expert faculty as they discuss stage-specific management approaches for COVID-19 pneumonia.
Lorenzo Dagna, MD, FACP, FEFIM(Hon)​​ and Evangelos J. Giamarellos-Bourboulis, MD, PhD​​

Cytokine Blockade in COVID-19​: Timing and Patient Selection Are Key​

Join our expert faculty as they discuss cytokine-targeted therapies in patients with COVID-19.
Lorenzo Dagna, MD, FACP, FEFIM(Hon)​​ and Evangelos J. Giamarellos-Bourboulis, MD, PhD

Navigating the Future: Applications Beyond COVID-19

Join our expert faculty as they discuss the wide applications of agents targeting hyperinflammation.
Mihai G. Netea, MD, PhD​